Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Tax Liability: 2013-2022

Historic Non-Current Deferred Tax Liability for Amphastar Pharmaceuticals (AMPH) over the last 9 years, with Dec 2022 value amounting to $144,000.

  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability fell 16.94% to $201,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $201,000, marking a year-over-year decrease of 16.94%. This contributed to the annual value of $144,000 for FY2022, which is 73.03% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Non-Current Deferred Tax Liability stood at $144,000 for FY2022, which was down 73.03% from $534,000 recorded in FY2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability peaked at $1.0 million during FY2018, and registered a low of $144,000 during FY2022.
  • Moreover, its 3-year median value for Non-Current Deferred Tax Liability was $534,000 (2021), whereas its average is $473,000.
  • Data for Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability shows a maximum YoY slumped of 73.03% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability stood at $1.0 million in 2018, then declined by 15.91% to $867,000 in 2019, then dropped by 14.53% to $741,000 in 2020, then declined by 27.94% to $534,000 in 2021, then tumbled by 73.03% to $144,000 in 2022.